Figure 1 - Proposed maladaptive hyperinflammatory response to SARS-CoV-2 infection (Perico N, Cortinovis M, Suter F, Remuzzi G. (2022))
<< A few observational studies have tested NSAIDs [non-steroidal anti-inflammatory drugs] (especially relatively selective COX-2 inhibitors), often as part of multipharmacological protocols, for early outpatient treatment of COVID-19. The findings from these studies are promising and point to a crucial role of NSAIDs for the at-home management of people with initial COVID-19 symptoms. >>
<< Celecoxib, ibuprofen, and nimesulide should be avoided in children younger than 12 years, whereas aspirin should be taken only under prescription and at the dose recommended by the family doctor. >>️
️
Norberto Perico, Monica Cortinovis, Fredy Suter, Giuseppe Remuzzi. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. The Lancet Infectious Diseases. doi: 10.1016/ S1473-3099(22)00433-9. Aug 25, 2022.
FonT
therefore the deadly infection by sars-cov-2 that has generated so much suffering, pain, and dead everywhere it is recently hypothesized that it could easily be treated at home (an early treatment) with some success.
Also
keywords 'covid-19' and 'NSAIDs' in PubMed
Also
aproposito di '1or2achoos' (da Wuhan (?)) ... FonT. Jul 13 2022.
Keywords: virus, coronavirus, sarscov2, 2019ncov, covid19, 1or2achoos
Nessun commento:
Posta un commento
Nota. Solo i membri di questo blog possono postare un commento.